Microbial world

🤣🤣

Please follow my other page on instagram and write done in comment section 😌

reviewview (@revi_ewview_with_me) • Instagram photos and videos 26 Followers, 932 Following, 4 Posts - See Instagram photos and videos from reviewview ()

England has recently become the first country in Europe to offer a new, faster form of immunotherapy treatment for cancer patients through the NHS.

This new method involves administering drugs like atezolizumab (Tecentriq) and nivolumab (Opdivo) via a subcutaneous (under-the-skin) injection, which significantly reduces treatment time from up to an hour to just 3–7 minutes.

This advancement improves patient experience and convenience, allowing them to spend less time in hospitals while receiving the same level of clinical care.

These injections are approved to treat up to 15 different types of cancer, including lung, bladder, breast, liver, kidney, oesophageal, head and neck, and skin cancers.

The medicines work by boosting the immune system’s ability to identify and attack cancer cells. They are known as checkpoint inhibitors and are already used in standard intravenous form, but this new injection method is much faster and more efficient.

The rollout is considered cost-neutral for the NHS due to negotiated pricing agreements, while also freeing up thousands of clinician hours each month.

Clinical trials, such as IMscin001, demonstrated that the subcutaneous version is equally effective and safe compared to the traditional intravenous route.

This innovation represents a significant step forward in cancer treatment accessibility and efficiency within the UK healthcare system.

Guess? 🧠 🤔

Aspergillus Niger
Aspergillus fumigatus

Mushrooms Might Be Talking And They Have a 50-Word Vocabulary 🍄🧠

It turns out the quietest organisms on Earth might not be so silent after all. According to a groundbreaking study led by Professor Andrew Adamatzky from the University of the West of England, mushrooms may actually ‘talk’ to each other and they may be using something like a language to do it.

The research, published in Royal Society Open Science in 2022, revealed that fungi like enoki and split gill mushrooms produce rhythmic electrical impulses through their mycelial networks the underground root-like threads that connect them. By inserting ultra-sensitive electrodes into these networks, scientists detected spike patterns that looked strikingly similar to the way humans structure words and sentences.

Some of these electrical bursts even formed consistent clusters, suggesting the existence of a fungal “vocabulary” of up to 50 distinct words. While it’s still unclear whether this truly counts as language in the way we understand it, the implications are wild: mushrooms could be communicating, perhaps sharing information about their surroundings, signaling danger, or coordinating growth.
This isn’t just mind-blowing it’s a reminder that the natural world is packed with hidden complexity. Beneath the forest floor, fungi might be engaged in a silent, electrical conversation, creating what some call the “wood wide web.”

So next time you pass a mushroom, remember: you might be walking over a living, pulsing, talking network. One that speaks in quiet sparks and has more to say than we ever imagined. 🌍⚡🍄

Copied

Shout out to my newest followers! Excited to have you onboard! Celestin Kalkazia, Uzee Chimezie

In June 2025, the U.S. Food and Drug Administration (FDA) officially approved Yeztugo (lenacapavir) as the world’s first twice-yearly injection for HIV prevention (PrEP).

Developed by Gilead Sciences, this landmark drug offers long-term protection from HIV with just two subcutaneous shots per year.

The approval is based on extensive clinical trials under the PURPOSE 1 and 2 studies, which showed near-perfect efficacy—zero new infections in cisgender women and only two infections across a broader population of over 2,000 individuals.

This brings its protective rate to approximately 99.9%, making it the most effective and long-acting HIV prevention method available today.

Lenacapavir works by targeting the HIV capsid, a protein shell that encases the virus’s genetic material.

By inhibiting this capsid, the drug prevents HIV from replicating inside human cells.

Unlike daily oral PrEP options like Truvada or Descovy, Yeztugo is designed to overcome common adherence issues by requiring just one injection every six months. This simplifies prevention for at-risk

populations, especially those who struggle with daily medication routines.

While the approval is being hailed as a major victory in the global fight against HIV, access and affordability remain concerns.

The U.S. list price for a year’s supply is expected to be around $28,000, though Gilead has committed to providing generics to 120 low-income countries and producing up to 10 million doses by 2026.

Global health experts see this breakthrough as a turning point that could drastically reduce new HIV infections—if distribution is equitable and timely.

In summary, Yeztugo's approval represents a critical milestone in HIV prevention science, combining exceptional efficacy, convenience, and innovation.

It has the potential to reshape the future of HIV prevention—especially if healthcare systems can ensure widespread access to those most in need.

Shout out to my newest followers! Excited to have you onboard! Mhamad Othman

This Single-Celled Microbe Can Transform Into a Multicellular Creature 🦠😮👏

Aspergillus types🧫🍄